Article thumbnail

The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab

By G. Dumitrescu, A. Amiot, P. Seksik, C. Baudry, C. Stefanescu, C. Gagniere, M. Allez, J. Cosnes and Y. Bouhnik
Publisher: Wiley
Year: 2015
DOI identifier: 10.1111/apt.13393
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.